Skip to main content

Advancing science and improving human health by

unlocking measurement of forces and interactions in biology

Jump to:

Enter a pilot study proposal for your chance to win a z-Movi and cell avidity support for 1 week

Apply now

Discover LUMICKS

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments allow researchers – for the first time – to build the crucial and as yet unfinished bridge between structure and function at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

Our goal is to advance science and improve human health by providing tools that unlock the measurement of forces and interactions in biology to provide unparalleled insight into the fundamental cause of disease and the potential for drug optimization. These technologies are rapidly evolving as a mainstream approach in academic and pharma research for the study of DNA-binding proteins, molecular motor activity, protein folding, and the interactions between immune and cancer cells.

Do you want to see your biomolecules or cells in action?  Contact us for a demo!

Explore our products & applications

Reveal biomolecular processes
with dynamic single-molecule analysis

Obtain direct proof of the mechanisms of biomolecular processes by making real-time videos of your molecules in action with our dynamic single-molecule microscopes.

Study molecular mechanisms involved in DNA organization, repair, replication, editing, and transcription.

Study how proteins fold correctly and undergo conformational changes to accomplish their biological function.

Study the activity and mechanical properties of cytoskeleton filaments and their motors.

Measure protein droplet assembly, fusion, and droplet or cellular properties in real-time.

Accelerate immunotherapy
with cell avidity analysis

Measure the binding strength between cells and their targets with the z-Movi®Cell Avidity Analyzer to accelerate the development of immunotherapeutic strategies.

CAR T cells

Select optimally-functioning CAR T cells based on their avidity and fine-tune the desired avidities to avoid on-target/off-tumor binding.

TCR T cells

Improve the functional correlation of TCR T cells by replacing affinity measurements with avidity. Reveal TCR modified T cells with optimal avidity that improve T cell responses.

Cell engagers

Test the binding avidity associated with different BsAb and compare the avidity of T cells engaged by these BsAb to find the most desirable response.

CAR-NK / NK cells
Compare the avidity of NK or CAR-NK cells from different donors and correlate the respective outcomes to effector cell functionalities, such as cell killing.

Become a part of the team

Our ultimate dream is to advance science and improve human health. To achieve this together, we are looking for smart and open people with a passion for cutting-edge technology, who are curious to discover new areas and are creative in finding solutions for existing and future challenges.

“We are a flat company that [...] allows you to be thinking creatively and to be your own person at work. This makes me feel that I belong here.”

AidaEMEAI Field Application Scientist Manager

“We are working with things that have never been done before, [but] when you own something, you have the drive to really push to seek completion.”

AbelSoftware Engineer

“We have people from different parts of the world [...] and you get to know so many things, just by working here. People are extremely friendly, approachable and helpful.”

IreneField Application Scientist

Read our latest news

Press releases

Breakthrough Research Published in Nature Enabled by Dynamic Single-Molecule Analysis Reveals Crucial Structure-Function Insights into DNA Repair, Resulting in New Cancer Fighting Strategies

Amsterdam, the Netherlands – July 14th, 2023 – LUMICKS, a cutting-edge life science tools company and the leading supplier of dynamic single-molecule and cell avidity analysis instruments, today announced the publication of ground-breaking cancer research in Nature. The research, enabled by LUMICKS’ C-Trap® dynamic single-molecule analysis technology, reveals new crucial…
“Avidity Enhancement” As New Strategy for Improving CAR T Therapy for AML
Press releases
Cancer Cell Paper Identifies “Avidity Enhancement” As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia
Press releases
LUMICKS Appoints Andre Nel as Chief Financial Officer
Browse more of our press releases
Blog posts

Unveiling Key Mechanisms in Kinetochore-Mediated Chromosome Segregation with the C-Trap

Dr. David Barford's study unveils kinetochore dynamics using LUMICKS C-Trap, shedding light on chromosome segregation mechanisms
Blog posts
From Handshakes to Hugs: Embracing the Dynamics of Immunological Synapse Strength and Avidity 
Negative supercoiled
Blog posts
Towards safe and precise gene therapies: revealing the impact of DNA Supercoiling on CRISPR-Cas9 specificity
Browse more of our blog posts
Close Menu

For pricing, reach out to your application scientist or account manager

Open Email

Fill in our contact form, we will reach out to you!

Please include ‘Lakeview data analysis price inquiry’ in the Message box

Contact Us


Join our newsletter

Get exclusive news on the latest publications, product developments, events and breakthrough science.

By submitting the form you agree to LUMICKS' privacy policy. You can revoke your consent at any time.

Download our webinar recording:

 

Download our Cell Therapy (CAR-T, TCR, NK) applications deck